
Elon Musk’s “war” against Apple has apparently halted, according to the Twitter CEO.
Musk mounted a campaign against the iPhone maker Monday (Nov. 28), saying the company had “mostly” ceased its advertising on Twitter and had threatened to pull the social media platform from its App store.
He said — via a now-deleted meme — that he was prepared to “go to war” with Apple over the future of the Twitter app.
By Wednesday, however, things seem to have cooled, with Musk posting a video on Twitter recorded as he met with Apple CEO Tim Cook at the company’s headquarters.
“Good conversation,” Musk wrote. “Among other things, we resolved the misunderstanding about Twitter potentially being removed from the App Store. Tim was clear that Apple never considered doing so.”
PYMNTS has reached out to Apple for comment.
Ads account for nearly all of Twitter’s revenue, and Apple isn’t the only company reducing its advertising time on the platform. A number of brands — including General Mills and snack/candy giant Mondelez International — have either stopped or paused their ads since Musk took over as owner in October.
Related: Musk Sides With Epic In Battle Over Apple App Store Fees
In early November, he announced Twitter had seen “a massive drop in revenue, due to activist groups pressuring advertisers.”
Whatever the reason, Twitter has lost at least half of its top 100 advertisers, businesses that brought $750 million to Twitter’s notoriously weak balance sheet just this year.
In the middle of his conflict with Apple, Musk suggested that he could build his own phone based around Twitter, negating the need for either Google or Apple’s app stores. He’s also spoken of Twitter as the launching pad for “X, the everything app.”
And as PYMNTS noted earlier this week, making “Twitter into the X super app may be the only realistic way Musk, and his investor cohort, can manage to not lose their shirts on the $44 billion purchase of the platform,” although it’s obvious that much more work needs to be done.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas